Feedback / Questions
MYTX-011 - Mythic Therap
https://www.businesswire.com/news/home/20250531770472/en/Mythic-Therapeutics-Presents-Compelling-Efficacy-Data-from-its-Phase-1-KisMET-01-Study-Supporting-Best-in-Class-Potential-of-Novel-cMET--ADC-MYTX-011-in-Non-Small-Cell-Lung-Cancer-at-the-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting
May 31, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next